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Duetotheirhighlevelsofachievementandeﬃciency,imagedigitalizationandteletransmissiontoolsaremoreandmorefrequently
used. Applied to cellular haematology, these tools often contribute to diagnosis confrontation, sometimes within the framework
of therapeutic trials. We present one of the ﬁrst approaches of the use of telehaematology for the inclusion of patients in the
GOELAMS chronic lymphocytic leukaemia 98 trial. The advantages were (1) the creation of a unique, protected, stable data bank
that could be remotely consulted, (2) the use of digitized pictures which made expertise on identical documents possible, (3)
the facility of computer exchanges between experts, in terms of reception as well as replying time delays. We were able to set
out new standards of image sampling for CLL, solve the semantic divergences, and point out interobserver variability as regards
morphology. The limiting factors were the important need for expert investment, but they more importantly concerned the ﬁrst
line morphologists who should beneﬁt from adequate tools, in terms of computer equipment as well as members of staﬀ,s oa st o
apprehend this second reading system as a quality control procedure.
Copyright © 2009 J.-F. Lesesve and R. Garand. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
1.Introduction
“Expert” reviewing of microscopic data is a well-known
procedure in medical practice, within the framework of
cooperative studies with therapeutic, epidemiological, or
scientiﬁc purposes. In the current state of things, this
notion, however, mostly remains a theoretical one owing
to persisting practical diﬃculties in its implementation [1].
Telehaematology consists in sending pictures of camera-
digitized cells from one computer to another via the internet
network. It appears as something easy which is more and
more resorted to. Teletransmission of microscopic images
enables us to overcome the usual obstacles usually met
with traditional methods of smear reviewing (transporting
delays, glass slide breakages) and oﬀers new theoretical
advantages (above all standardization of the observed cells)
[2]. In practice, this teletransmission system remains under-
used in multicentric studies. Three GOELAMS protocols
(Groupe Ouest-Est d’Etude des Leuc´ emies Aigu¨ es et autres
Maladies du Sang—Western/Eastern group for the study of
acute leukaemias and other blood pathologies) have been
completed: our study on chronic lymphocytic leukaemia
(CLL) and two other ones on acute myeloid leukaemias. The
GOELAMS CLL 98 protocol is being achieved; our goal was
to develop the advantages and drawbacks of telehaematology
for patient inclusion.
2.MaterialsandMethods
2.1. Patients. The GOELAMS CLL 98 study is a randomized
multicentric study that compared the eﬀectiveness and
tolerance of an intensive treatment with autologous bone
marrow transplantation versus CHOP Binet treatment as
ﬁrst-line treatment in patients under 60 years of age, with
stage B or C CLL [3]. 86 patients were included on the
following criteria: blood lymphocytosis > 15 × 109/L or
> 5 × 109/L for at least 3 months, cytologic and histologic
medullary inﬁltrate ≥ 30%, stage B and C, between 18 and2 International Journal of Telemedicine and Applications
60 years of age, no preliminary treatment or chlorambucil
only for less than 6 months.
2.2. Methods. May Gr¨ undwald Giemsa stained blood smears
weresenttoanhaematologicalexpertlocatedeitherinNancy
(JFL)orin Nantes (RG)accordingtothe geographiclocation
of the center where the patients had been recruited, France
having been for that purpose arbitrarily divided into two
parts (East and West). The ﬁrst expert captured the digital
images of the cells and then sent those pictures to the
secondexpertviaateletransmission device.Theexpertswere
supposed to have at their disposal the complete blood count
and the immunophenotypes performed by the recruiting
center and sent to them either by post or via the internet
network (after having been scanned) in an attachment. The
aim was to obtain a fast second reading of the results
and provide the ﬁrst expert with feedback, the consensus
eventually being transmitted to the recruiting center. The
morphologicdocumentsweresavedinadigitizedvisual-data
bank, the smears could thus quickly be sent back to the labs
they initially came from.
The digital images were captured using an optical
photonic microscope at ×1000 magniﬁcation, an analogic
tri CCD camera, a computer connected to the Internet
network and to a secure web site (where the digitized
pictures could be collected by the ﬁrst expert and where the
second one could receive the ﬁles) (TRIBVN and CRIHAN
systems). The pictures of the lymphoid cells frequently
corresponded to an almost continuous sampling, supposedly
representative of the blood smears (ghost cells and poor
quality pictures having been removed). Each and every cell
was described, diﬀerent percentages could thus be obtained
(mature cells, cleaved cells, lymphoplasmocytoid variants,
etc.) and, following from this, morphologic classiﬁcation of
the CLL (common or atypical).
The recruiting center’s opinion as well as that of the ﬁrst
andsecondexpertsasregardscytologyandtheinterpretation
of the immunophenotypes by ﬂow cytometry were codiﬁed
thanks to a thesaurus which enabled standardization of
the vocabulary used by the diﬀerent specialists as well as
improved interpretation of the results (additional thesaurus
for haematology of the ADICAP code; Association pour
le D´ eveloppement de l’Informatique en Cytologie et en
Anatomopathologie—Association for the Development of
Computer science in Cytology and Anatomopathology),
regarding the morphology: typical CLL H400; atypical CLL
H 401 (mixed prolymphocytic), H402 (mixed pleomorphic),
H403 (other cytology, plasmocytoid).
3. Results
3.1. Workable Files. The duration of the protocol was
approximately 7 years (1st review: 29/November/1999; last
review: 05/January/2006). 86 patients were included but we
could only work on 79-patient data. Some ﬁles were indeed
not provided by the laboratories, either because they had
failed to send us the requested documents (5 patients) or
because data had been lost owing to laboratory relocation (2
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Figure 1: Cytologic concordance.
patients). 17 ﬁles were incomplete—with some parameters
missing such as the date of validation, the lymphocytosis,
the cytologic/immunological data. 56 ﬁles were digitized in
Nancy and 23 in Nantes.
3.2. Agreements between Experts
3.2.1. Morphology (Figure 1). Overall agreement was
obtained for 72% of the ﬁles (42 cases of typical CLL
and 4 atypical). In one case, the three morphologists
agreed to exclude the patient (non-Hodgkin lymphoma).
Disagreements were reported in 28% of the cases.
The diagnosis itself was not challenged, only the exact
morphologic classiﬁcation being at stake (CLL subtypes,
“minor” disagreements). Disagreements between the
opinions of the recruiter and both experts mainly consisted
of reclassiﬁcation of atypical towards typical CLL (ﬁve cases
out of eight) or diﬀerences regarding the morphologic
subtype of atypical CLL (two cases). In one case, the
experts changed the CLL subclass from atypical to typical.
Disagreements between the experts themselves occurred in
14% of the cases, the ﬁrst one having classiﬁed 6 CLL out
of 9 as typical whereas the second had identiﬁed them as
atypical. In 3 out of 9 CLLs, the two experts did not agree on
the morphologic subtype of atypical CLL. In another case,
utter disagreement (three diverging opinions) concerned
a ﬁle that had initially been identiﬁed as typical CLL and
then changed to atypical, the two experts disagreeing on its
morphologic subtype.
As a conclusion, all three agreed on a majority of ﬁles
and disagreed on minor aspects of a minority of cases.
Morphologicagreementisthuspossibletoachieve.Cytologic
classiﬁcation can consequently deﬁnitely be regarded as a
reliable and repeatable tool. Last but not least, as for “diﬃ-
cult” cytologies, the method opened the door to discussion,International Journal of Telemedicine and Applications 3
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Figure 2: Flow cytometry concordance (Matutes scores).
which had not really been the case up to then (the specialist
being isolated in their centre and the expert diﬃcult to reach
timely).
3.2.2. Immunophenotype (Figure 2). The results of the
immunophenotypes were sent to the ﬁrst expert by the
recruiting centre along with the blood smears. Everything
(the immunophenotypes and the digitized pictures) was
then transferred to the second expert, either by e-mail in
an attachment or by post, with a one-day time-lag. The
histograms were re-interpreted, and Matutes scores were
calculated. All patients had a Matutes score of 4 or 5, except
for 2 cases with a score of 3 and one case with a score of
1 (not considered as CLL). Overall agreement between the
3 observers was 86%, including the 3 patients with a score
≤3. Disagreements dawned in 14% of the ﬁles. In 4% of the
cases, the recruiter’s opinion was diﬀerent from the experts’
point of view whereas in 10% of cases, the experts disagreed,
one ofthem however concurring to the recruiter’s viewpoint.
Disagreements were related to the calculation of the score,
between 4 (2 observers) and 5 (1 observer) or vice-versa.
The CLL diagnosis was thus never questioned, whatever
the morphology. There was no utter disagreement (three
diverging opinions). We could thus conclude that as far as
immunophenotypicaldiagnosisisinvolved,globalconsensus
is not out of reach.
3.3. Methodology. We aimed to assess its feasibility (in terms
of eﬃciency, practical side, etc.).
3.3.1. Number of Digitized Cells per Digitized Pictures and
per Files (Figures 3–5). This criterium is essential for the
feasibility of this method (review is quicker when cell
concentration is higher) and quite a number of cells have to
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Figure 3: Distribution of the number of lymphocytes per image.
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Figure 4: Distribution of the number of images per ﬁle.
be analyzed before giving one’s opinion. The total number
of images acquired in this protocol was 1460, consisting
of 2938 lymphocytes, which (theoretically) represents an
average of 2 cells per picture. The minimum number of
lymphocytes captured per image was 1 and the maximum
17, which corresponded to a 508 × 109/L lymphocytosis,
namely the highest concentration that could be found in
our series (Figure 3). The minimum number of pictures per
ﬁle was 9 and the maximum 48 (Figure 4). The minimum
number of captured lymphocytes for one ﬁle was 15 and
the maximum 121 (corresponding to the 508G/L lympho-
cytosis, Figure 5), the median being 38. 42 lymphocytes
per ﬁle was the theoretical average (2938 photographed
lymphocytes/70 ﬁles). Consequently, photographing around
40 lymphocytes per patient seemed appropriate to us as
regards this type of lymphoproliferative syndrome. This
ﬁgure enables the observer taking the pictures to provide
the others with a sampling representative of the blood
smear and the expert can thus reach a relevant diagno-
sis.
3.3.2. Number of Lymphocytes Photographed and Complexity
of the Morphologic Diagnosis (Figure 6). The CLLs were
classiﬁed either as typical (code ADICAP H400) or atypical
morphology (H401, H402,H403). Wechosetofocusonlyon
thecaseswherebothexpertshadasimilarcytologicdiagnosis
(N = 53). The average number of lymphocytes captured
per ﬁle was 40 (±21, N = 40) for typical CLL versus 46
(±13, N = 13) for atypical CLL. The diﬀerence in averages
between the typical and atypical CLLs was not signiﬁcant4 International Journal of Telemedicine and Applications
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Figure 6: Average numbers of captured lymphocytes functions of
t h em o r p h o l o g i ct y p eo fC L L .
(P>. 2, student’s t-test). The number of digitized lympho-
cytes is thus not signiﬁcantly higher when the morphology is
atypical.
3.3.3. Cytologic Agreement/Disagreement and Number of
Lymphocytes Photographed (Figure 7). The average number
of lymphocytes captured per ﬁle was 41 (±19, N = 53)
when both experts were in agreement and 42 (±10, N = 10)
when they disagreed. The diﬀerence between the averages of
captured lymphocytes was not relevant (P>0.2, student’s
t-test). The number of captured cells is consequently of no
inﬂuence on cytologic agreement.
3.3.4. Lymphocytosis and Number of Photographed Images
(Figure 8). A link between the lymphocytosis and the num-
ber of digitized images could be established (linear Pearson
coeﬃcient, −0.46). The higher the lymphocytosis, the less
images were taken. This is an important aspect as regards the
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practicalside,sincelesstimewasnecessarytosaveandmaybe
review the documents.
3.3.5. Delays of File Reception (Figure 9). In most cases,
the cytologic and immunological documents were sent to
one of the experts by post, who then looked after their
digitization. Two cases were transmitted directly by e-mail
(contrary to what was mentioned in the protocol). In 30%
of the cases, the ﬁles were received within one month. For
the remaining 70%, the time delay was several months and
sometimes even reached years! The delay between the two
experts using the teletransmission device was less than two
weeks in 70% of the cases and 84% of the ﬁles were validated
within one month of receipt. However, 16% of the ﬁles
were validated after more than one month (16 weeks being
the maximum). Telehaematology enables validation to be
completed approximately 12 times faster than the traditional
way of review (by post).International Journal of Telemedicine and Applications 5
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Figure 9: Time delay between initial diagnosis and ﬁrst review.
4. Discussion
This study aimed at putting forward one of the ﬁrst
approaches of the use of telehaematology for the quality
control of diagnosis [4]. The GOELAMS CLL 98 trial was
chosen to assess this second reading system (blood smears
and immunophenotypes). Above all, we wanted to question
the eﬃciency of the method in use since second reading
throughresorttodigitizedpicturesis,contrarytowhatmight
be assumed, a technique which remains largely underused
[5].
As regards the morphologic classiﬁcation, we noticed
unanimous agreement in more than 2/3 of the cases. When
the morphology was typical, agreement on the cytologic
conclusion was almost systematic. 8 cases of disagreement
have been reported—the experts having an opinion diverg-
ing from the recruiting centre. This can be due to the limited
experienceofthe latterintheﬁeld,whichjustiﬁestherequest
for a second expert opinion for the inclusion of patients.
Furthermore, the experts themselves disagreed on 9 cases.
This might seem weird in so far as each digitized cell was
analyzed by both experts to classify the CLL. It proves that
the same cell can be classiﬁed diﬀerently by two diﬀerent
specialists. Cytology is above all a matter of interpretation,
thus implying a potentially important bias. On the whole,
the three specialists agreed on most cases; and the experts
disagreed on minor aspects of a minority of cases (the
CLL diagnosis was never challenged). Immunophenotypical
proﬁle of the CLLs is the second important means to
classify the illness. Matutes scores were really helpful for the
diagnosis. In our study, almost all the patients scored 4 or
5, as expected. One patient scored 1, which enabled us to
leave CLL aside, since it corresponded to the morphology of
a leukaemic phase of lymphoma. The experts’ conclusions
had no impact on the score which had been predeﬁned by
the recruiting centre. Indeed, despite global disagreement
in 13% of the cases, the only evolution of Matutes scores
was between 4 and 5, both indicating CLL. These diﬀerences
could be accounted for by the diﬀerent threshold levels used
for the isotypic controls, which modiﬁed the percentage
of cells considered positive as well as the ﬂuorescence
intensity, thus aﬀecting data interpretation. On the whole,
global agreement between the three specialists prevailed. The
diﬀerences of interpretation were not signiﬁcant. We can
thus conclude on the reliability of the laboratories where
the immunophenotypes had been performed and say that
they are the most capable of interpreting their histograms.
Agreement was more frequent with the immunophenotypes
than with cytology, which can be explained by the fact
that immunophenotypical interpretation is more objective
(charts are provided) compared to the relatively subjective
dimension of cytologic analysis (“individual” morphologic
interpretation).
So as to increase the feasibility of this type of inclusion
protocol, we suggest sending the digitized pictures only
accompanied with the data related to the Matutes scores as
suﬃcient to validate patient inclusion.
Although no minimal standards of sampling had been
pre-established, we found around 40 lymphocytes per ﬁle
to be appropriate for this type of lymphoproliferative
syndrome. This ﬁgure is in agreement with the mini-
mum threshold of 30 lymphocytes previously established
in another study, which consisted in requesting for speciﬁc
opinion on various haematological disorders [1]. That ﬁgure
can be used for both typical and atypical CLL since we
have shown that there is no signiﬁcant diﬀerence between
the average numbers of captured cells in relation to the
complexityofthediagnosis.Moreover,(dis)agreementabout
the CLL codiﬁcation between the two experts was not
related to the number of captured lymphocytes. Time is
another parameter that has to be taken into account in
the evaluation of the feasibility of the method. 60 to 90
minutes were necessary to digitize, classify and send the
ﬁle. We wanted to ﬁnd out whether there was a connection
between the number of pictures taken (and thus the time
spent on each smear) and the lymphocytosis. This indeed
appears to be true to some extent, and although the
tendency was not very clear (“visual” analysis of the slope
of the trendline), a statistical link could yet be established.
The number of images taken and the lymphocytosis were
inversely correlated. Nevertheless, the specialist had to use
the maximal magniﬁcation available (×100) since analysis
of the cellular detail (shape and structure of the cell and
its nucleus) is crucial for morphologic subclassiﬁcation.
However, with such a magniﬁcation, ﬁnding more than
one cell in each image proved unfrequent, most images
containing only one cell, whatever the cellular density on
the smear may have been (high lymphoytoses > 100 ×
109/L being included). What is important was to manage
to get a sampling which was representative of the smear’s
morphologic variability (diagnostic criterium). An average
of around 40 lymphocytes, whatever the lymphocytosis,
seemed to make this possible (practical criterium). A line
sampling enabled us to meet these two requirements in most
cases.
The time delay between the recruiting centre and the
ﬁrst expert for ﬁles sent by post was around one month
for one third of the ﬁles, which can arbitrarily be deﬁned
as “acceptable”. But for the remaining 2/3, the delay was
tantamount to several months and even years. One of
the causes that could be put forward is that the centres
which are requested to participate in cooperative studies are
often reluctant to part from their records and archives. The6 International Journal of Telemedicine and Applications
delaysanduncertaintiescausedbysendingfragiledocuments
by post indeed represent a serious drawback: the archive
materials are frequently deteriorated (broken blood smears)
and are not available for quite long periods of time. It was
precisely one of the aims of the second reading protocol—
namely to avoid parcel sending (at least from an expert to
the other) after having certiﬁed that the original documents
would be returned to the recruiting center once the digitized
ﬁle was ready. Teletransmission clearly improved the second
reading system. However, it is not yet completely satisfying
since 16% of the ﬁles had still not been validated after a
month. That can be explained by a two-week maintenance of
theCRIHANsecurewebsiteandbytheexpert’sunavailability
or material incapability, and so forth. However, electronic
data interchange has proved much faster than traditional
mail (by post). This is obviously due to a greater speed of
transmission (a few seconds instead of several days, or even
more). We, however, believe that “motivation” plays a key
role and is even more crucial. A direct email enclosing a
request for a second reading is probably a greater incentive
than more anonymous form letters. The time taken for the
expert to reply was, for the most part, compatible with that
of clinical decision-making. The expert’s role was mainly to
give a second opinion (validation). As for traditional second
reading (slides sent by post or seminars such as “Forum
Workshop”), the slowness of the whole thing prevented the
results from being returned on time and, as such, they often
came too late to inﬂuence in any way the therapeutic options
that had already been chosen (for CLLs, a one-month
time delay remains acceptable). Thanks to telehaematology,
w ec a nt h u sm o v eo nf r o mah y p o t h e t i c a la n dd u b i o u s
retroactive assessment to an upstream quality control of
the therapeutic decisions. The notion of time delay could
even be eliminated thanks to software that enable two users
to establish a direct connection and thus to hold a real-
time dialogue and comment upon an image simultaneously
thanks to a mobile pointer [5]. For example, that system
allowed an expert to guide a nonspecialist technician and
thus conﬁrm the diagnosis. But however tempting this
solution may appear, it should deﬁnitely not be privileged
for ﬁnancial reasons, since this equipment is far more
expensive [1, 6]. Indeed, the expert (from where he is) is
supposed to perform the tasks that the local morphologist
would normally be doing; the expert thus replaces the
morphologist instead of merely assisting them. The experts’
availability being one of the major parameters accounting
fortheslownessoftelepathology’sdevelopment,askingthem
to become substitutes, does not seem very realistic to us
[1].
Last but not least, one of the major gains was the creation
of an objective database that was available for remote
consultation (geographically and temporally). Indeed, one
of the aims of the biological protocol was to set up a
morphologic database. All the digitized pictures were saved
in the CRIHAN secure website and were thus freely available
to users, especially in case of dispute over the conclusions. A
ﬁrst step has been taken to solve the semantic inconsistencies
related to the use of classiﬁcations [7]. The diversity of
interpretations now remains to be tackled since, as our
study showed, two experts do not necessarily classify the
same cell in the same category, even though the diﬀerences
are almost negligible. The creation of this database also
enabled us to keep track of the initial blood smear (which
is at present not mandatory in the majority of therapeutic
protocols) and thus to keep an eye on disease evolution.
As every time information is exchanged, respect of medical
secrecy has to be ensured. Using a speciﬁcally dedicated talk-
back secure website enabled us to guarantee the safety of
sent and received messages since passwords were required.
All messages posted through the secure website were saved
(including the content and the replies) and both document
history and traceability were preserved. Consequently, it is
essential for good practice to use a dedicated secure website,
as we did, rather than traditional emails and the protocol did
not call this into question.
We sometimes noticed the diﬃculties encountered by
some recruiting centres to provide us with the ﬁles. The time
delays sometimes reached months, and even years. Several
hypotheses can be put forward: (1) the lack of experience of
small-size laboratories in taking part in protocols and the
fact that they also keep less track of patient ﬁles, (2) the
innovative dimension of our protocol, which consisted in
assessing the validity of the initial diagnosis, (3) the main
(therapeutic) objective of the protocol involved that the
specialist was supposed to hand over data to “their” expert
so that transmission of the biological ﬁles could be properly
achieved (the need for which might have been overlooked
by the specialist, especially for such a common pathology
as CLL). We thus once again would like to stress the
importance of establishing a dialogue between the specialists
and the experts, from which transmission of the information
about the biological and therapeutic protocols would follow.
What can also (especially) be called into question is the
current chronic underequipment of the laboratories, both
in terms of speciﬁc hardware and members of staﬀ.T h e
current implementation of teletransmission devices will
allow on the premises digitization of the ﬁles, which will
consequently simplify the procedure and lead to better
compliance and eﬃciency of such types of second reading.
Moreover, the conditions regulating resort to “experts” and
to “telehaematology expert networks” remain vague in so far
as this activity has not yet been oﬃcially taken into account
by the healthcare authorities and consequently does not
beneﬁt from any speciﬁc status or any guidelines as far as the
ﬁnancial aspect is involved [8]. There are unfortunately very
few documented experiments that we know of dealing with
that kind of cytologic activities [4, 9]. We could thus hardly
ﬁnd any data to compare our conclusions with. However,
several initiatives implying telehaematology have recently
been or are currently being implemented in France (Table
1). Moreover, databases associated with second reading
protocols via teletransmission devices have been set up.
However, the conclusions of such second readings are not
awaited to introduce treatment. City/hospital networks have
been created [10]. To ﬁnish, there are a few websites, such
as M´ edecin’images or the one of the Coll` ege de Hˆ opitaux
G´ en´ eraux thanks to which high quality exercises can be
performed via teletransmission [11].International Journal of Telemedicine and Applications 7
Table 1
Pathology Protocol Chair(wo)man Starting date
French protocols using telemedecine for mandatory morphological consensus whorkshop (needed for inclusion)
Chronic lymphocytic
leukemias
GOELAMS LLC 98
JF Lesesve (Nancy)
and R Garand
(Nantes)
Sept-1999 (achieved)
Acute myeloblastic
leukemias (adults)
GOELAMS 3
S Daliphard (Reims)
and V Leymarie
(Strasbourg)
March-2002
(achieved)
Acute myeloblastic
leukemias (adults)
LAM-SA 2002 P Mossuz (Grenoble) April-2004 (in
progress)
Acute myeloblastic
leukemias (pediatric)
ELAM02 O Fenneteau (Paris
Robert Debr´ e)
March-2005 (in
progress)
French morphological data banks using telemedecine
Myelomas IFM M Zandecki (Angers) 2000 (achieved)
Acute myeloblastic
leukemias
Matchslide G Flandrin (Paris
Necker)
01/11/2001
(achieved)
Red blood cells Teleslide
G Flandrin (Paris
Necker), JF Lesesve
(Nancy),
01/09/2003
(achieved)
O Fenneteau (Paris R
Debr´ e), T Cynober
(Kremlin Bicˆ etre)
Myelodysplastic
syndromes
GFMDS FP i c a r d( P a r i s
Cochin) Dec-04 (in progress)
French morphological quality-control tests
All topics Medecin’image JX Corberand
(Toulouse)
All topics Coll` ege des Hopitaux G´ en´ eraux/teleslide D Lusina, JM Martelli
(Aulnay sous bois)
January-2003 (in
progress)
Forum whorkshops (congresses of the “Groupe Franc ¸ais d’H´ ematologie Cellulaire”) open to discussion
Myeloproliferative
diseases
Congress GFHC SMP2005, Nantes R Garand (Nantes) 2005.05.17
B-cell
lymphoproliferative
syndromes
Congress GFHC SLP2007, Lyon R Garand (Nantes) 2007.05.22
Acute leukemias and
myelodysplastic
syndromes
Meeting GFHC, Paris S Daliphard (Reims) 2006.11.09
Thrombopenia et
thombopathies
(excluding
malignancies)
Meeting GFHC, Paris S Daliphard (Reims) 2007.11.28
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